| Literature DB >> 35268605 |
Boris V Nemzer1,2, Fadwa Al-Taher1, Alexander Yashin3, Igor Revelsky4, Yakov Yashin3.
Abstract
Cranberries are a rich source of bioactive compounds that comprise a healthy diet. Cranberry is abundant in nutritional components and many bioactive compounds that have antioxidant properties. Both American (Vaccinium macrocarpon) and European (Vaccinium oxycoccus) cranberry species are rich in polyphenols such as phenolic acids, anthocyanins and flavonoids, and is one of the few fruits that is high in proanthocyanidins, which is linked to many health benefits. The review systematizes information on the chemical composition of cranberry, its antioxidant effect, and the beneficial impact on human health and disease prevention after cranberry consumption, and in particular, its effect against urinary tract inflammation with both adults and children, cardiovascular, oncology diseases, type 2 diabetes, metabolic syndrome, obesity, tooth decay and periodontitis, Helicobacter pylori bacteria in the stomach and other diseases. Additional research needs to study cranberry proteomics profiling, polyphenols interaction and synergism with other biologically active compounds from natural ingredients and what is important in formulation of new functional foods and supplements.Entities:
Keywords: anthocyanins; antioxidant; cranberry; polyphenols; proanthocyanidins; urinary tract infection
Mesh:
Year: 2022 PMID: 35268605 PMCID: PMC8911768 DOI: 10.3390/molecules27051503
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Cranberries, raw, Nutritional value per 100 g.
| Name | Amount | Name | Amount |
|---|---|---|---|
| Water | 87 g | Vitamin E | 1.3 mg |
| Energy | 46 kcal | Vitamin K | 5 µg |
| Carbohydrates | 12 g | Vitamin A, as retinol | 3 µg |
| Sugars | 4.3 g | Vitamin A, IU | 63 IU |
| Dietary fiber | 3.6 g | Calcium | 8 mg |
| Fat | 0.1 g | Iron | 0.23 mg |
| Protein | 0.5 g | Magnesium | 6 mg |
| Thiamine (B1) | 0.012 mg | Manganese | 0.27 mg |
| Riboflavin (B2) | 0.02 mg | Phosphorus | 11 mg |
| Niacin (B3) | 0.101 mg | Potassium | 80 mg |
| Pantothenic acid (B5) | 0.295 mg | Sodium | 2 mg |
| Vitamin B6 | 0.057 mg | Zinc | 0.09 mg |
| Folate (B9) | 1 µg | Copper | 0.06 mg |
| Vitamin C | 14 mg | Selenium | 0.1 µg |
Reference: [11].
Phytonutrients in different cranberry fruit cultivars.
| Name | Polyphenol Content and Triterpenoids | Analytical Method | Reference |
|---|---|---|---|
|
| |||
| Delfinidyn derivatives | 31.27–43.87 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Delfinidyn-3-O-glucoside | 1.1–1.8 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Cyanidin derivatives | 442–967 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Cyanidin-3-O-galactoside | 119.9–180.0 mg/100 g dm | LC/MS Q-TOF and | [ |
| Cyanidin-3-O-glucoside | 5.5–7.3 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 2.3% | HPLC-UV/MS | [ | |
| 2.8% | HPLC-PDA | [ | |
| Cyanidin-3-O-arabinoside | 64.5–95.6 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 19% | HPLC-UV/MS | [ | |
| 20.2% | HPLC-PDA | [ | |
| Peonidin-3-O-galactoside | 131.3–310.3 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 32.7% | HPLC-UV/MS | [ | |
| 29.6% | HPLC-PDA | [ | |
| Peonidin-3-O-arabinoside | 42.9–95.2 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 6.7% | HPLC-UV/MS | [ | |
| 19.8% | HPLC-PDA | [ | |
| Peonidin derivatives | 192–666 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Malvidin derivatives | 29.85–58.85 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Malvidin-3-O-arabinoside | 1.4–1.9 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Total anthocyanins | 695–1716 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 3.60–152.2 mg/100 g dm | HPLC-UV/MS | [ | |
| 12.2–227.8 mg/kg dm | HPLC-PDA | [ | |
| 0.13–2.27 mg/g fw | pH differential method | [ | |
|
| |||
| p-Coumaric acid | 2–245 µg/g dw | HPLC/ESI-MS/MS | [ |
| p-Coumaroyl hexose | 8.6–13.9 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| p-Coumaroyl hexose | 3.6–50.0 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| p-Coumaroyl derivatives | 210–451 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Chlorogenic acid | 72.00–129.62 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 26.6–79.2 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| 6–47 µg/g dw | HPLC/ESI-MS/MS | [ | |
| Caffeic acid | 5–123 µg/g dw | HPLC/ESI-MS/MS | [ |
| Caffeoyl hexoside | 92.7–190.2 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Caffeoyl hexoside isomer | 10.9–17.5 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Caffeoyl and derivatives | 39.93–68.28 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Ferulic acid | 4–39 µg/g dw | HPLC/ESI-MS/MS | [ |
| Total phenolic acid | 327–649 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
|
| |||
| Myricetin-3-O-galactoside | 156.5–348.4 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 2 µg/g dw | HPLC/ESI-MS/MS | [ | |
| 4.61 mg/100 g fw | HPLC-PDA and HPLC-ESI/MS | [ | |
| Myricetin-3-O-glucoside | 1.8–6.6 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 8.68 mg/100 g fw | HPLC-PDA and HPLCESI/MS | [ | |
| Myricetin-3-O-pentoside | 6.3–55.6 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Myricetin-3-O-glucoronide | 19.0–38.5 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Myricetin-arabinoside | 8–273 µg/g dw | HPLC/ESI-MS/MS | [ |
| 5.68 mg/100 g fw | HPLC-PDA and HPLC-ESI/MS | [ | |
| Sinapoyl derivatives | 4.36–5.82 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Myricetin derivatives | 496–926 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Quercetin-3-O-galactoside | 294.6–375.8 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 54–126 µg/g dw | HPLC/ESI-MS/MS | [ | |
| 12.02 mg/100 g fw | HPLC-PDA and HPLC-ESI/MS | [ | |
| Quercetin-3-O-pentoside | 21.2–122.9 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Quercetin-3-O-glucoside | 4.8–11.5 mg/100 g | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 14.25 mg/100 g fw | HPLC-PDA and HPLC-ESI/MS | [ | |
| Quercetin-p-conmaroyl-hexoside | 1.3–13.3 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Quercetin-3-O-rhamnoside | 6.2–13.3 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 343 µg/g dm | HPLC/ESI-MS/MS | [ | |
| 7.32 mg/100 g fw | HPLC-PDA and HPLC-ESI/MS | [ | |
| Quercetin-rutinoside | 12.0 mg/100 g fw | HPLC-PDA and HPLC-ESI/MS | [ |
| Quercetin-acetyl-glucoside | 13.58 mg/100 g fw | HPLC-PDA and HPLC-ESI/MS | [ |
| Quercetin derivatives | 107–225 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Methoxyquercetin | 1.7–25.7 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Methoxyquercetin | 3.4–61.0 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Methoxyquercetin | 33.31–43.04 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Total flavonols | 643–1088 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
|
| |||
| (+)-Catechin | 2.79–7.53 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 19.6–24.5 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| 0.33–13.01 mg/100 g fw | UHPLC-UV-MS | [ | |
| (−)-Epicatechin | 27.46–56.84 mg/100 g dm 47.5–60.8 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 0.22–10.68 mg/100 g fw | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| UHPLC-UV-MS | [ | ||
| A-type PA-dimer | 16.94–32.07 mg/100 g dm 14.5–108.7 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 0.22–9.75 mg/100 g fw | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| UHPLC-UV-MS | [ | ||
| A-type PA-trimer | 27.82–76.94 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 15.1–53.8 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| 0.14–10.01 mg/100 g fw | UHPLC-UV-MS | [ | |
| A-type PA-tetramer | 41.51–65.61 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 18.2–40.1 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| B-type PA-dimer | 12.62–36.75 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 5.3–203 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| 0.56–27.50 mg/100 g fw | UHPLC-UV-MS | [ | |
| B-type PA-trimer | 0.04–2.93 mg/100 g fw | UHPLC-UV-MS | [ |
| Polymeric | 651–1109 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Sinapyl hexose | 2.0–3.3 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Total flavan-3-ols and | 860–1283 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Sum Phenolic compounds | 3428–3936.4 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| Total polyphenols | 192.1–3742 mg/100 g fm | UV/Vis spectrophotometer | [ |
|
| |||
| Ursolic acid | 1044–1714 mg/kg dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 2466.1–2850.6 mg/kg dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| 372.97 mg/g fw | HPLC-DAD | [ | |
| Oleanolic acid | 894–1137 mg/100 g dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 16.2–25.6 mg/kg dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| 79.16 mg/g fw | HPLC-DAD | [ | |
| Betulinic acid | 635–824 mg/kg dm; | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 36.3–100.1 mg/kg dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| Sum Triterpenoids | 2892–3671 mg/kg dm | LC/MS Q-TOF and UPLC-PDA-FL | [ |
| 2528.0–3201.5 mg/kg dm | LC/MS Q-TOF and UPLC-PDA-FL | [ | |
| Total Sterols | 107.83 mg/g fw | HPLC-DAD | [ |
Note 1: dm—dry matter; dw—dry weight; fm—fresh matter; fw—fresh weight. Note 2: Terminology for Analytical methods: LC/MS Q-TOF—Liquid Chromatography/Mass Spectrometry Quadrupole Time-of-Flight. UPLC-PDA-FL—Ultra-performance liquid chromatography-photodiode array-fluorescence. UHPLC UV/MS—Ultra-high performance ultra-violet mass spectrometer. HPLC-UV/MS—High-performance liquid chromatography-ultra-violet mass spectrometer. HPLC-PDA—High-performance liquid chromatography/photodiode array. HPLC/ESI-MS/MS—High-performance liquid chromatography/electrospray ionization tandem mass spectrometry. HPLC-DAD—High-performance liquid chromatography-diode array detector.
Prevention of disease with cranberry consumption and proposed mechanisms.
| Disease Name | Proposed Mechanism | References |
|---|---|---|
| Urinary tract inflammation | A-type procyanidins in cranberry demonstrate anti-adhesive activity against | [ |
| Cystitis | A-type procyanidins in cranberry prevent adhesion of | [ |
| Oxidative stress | Polyphenols in cranberry alleviate intestinal oxidative stress and inflammation while improving mitochondrial dysfunction by quenching reactive oxygen species. | [ |
| Cardiovascular | Polyphenols in cranberry may reduce the risk of cardiovascular disease by increasing the LDL resistance to oxidation, hindering platelet accumulation, decreasing blood pressure. | [ |
| Obesity | Lyophilized cranberries reduced fat accumulation during preadipocyte differentiation by decreasing the number of receptors on the surface of target cells of the mRNA level of adipocyte fatty acid-binding protein (aP2), lipoprotein lipase (LPL), fatty acid synthase (FAS), hormone sensitive lipase (HSL) and perilipin 1 (PLIN1). Therefore, cranberries are effective in preventing the production of adipose tissue. | [ |
| Type 2 diabetes | Cranberries improved post-prandial glucose concentration due to high fat and inflammation and oxidation in diabetic individuals. | [ |
| Helicobacter pylori suppression | Non-dialyzable substances from cranberry obstruct the sialic acid-specific adhesion of | [ |
| Cancers | [ | |
| Rheumatoid arthritis | Quercetin, a flavonoid present in cranberry, is a powerful suppressor of the nuclear factor (NF)-ĸB-pathway. It also impedes the activities of cyclooxygenase and lipoxygenase, enzymes released after the stimulation of arachidonic acid, which is the initiator of an inflammatory response. Resveratrol, a polyphenol in cranberry, also has been shown to reduce inflammatory genes expression important for cardiovascular disease by regulating the NF-ĸB and JAK STAT3 pathways in cells. | [ |
| Tooth decay and periodontitis | Polyphenols in cranberry serve as dental anticaries agents by impeding the production of organic acids and the formation of biofilms by cariogenic bacteria. Additionally, they may reduce inflammation as well as the production and activity of proteolytic enzymes destroying the extracellular matrix in periodontal disease. These polyphenols also interfere with other activities such as formation of biofilm and adhesion of | [ |
| Infectious | PAC in cranberries block adhesion to and biofilm formation on target tissues of pathogens | [ |
| Kidney | Cranberries enriched with PACs can alleviate the complications associated with chronic kidney disease such as oxidative stress, inflammation and gut dysbiosis | [ |
| Intestinal microbiota | The rich cranberry content of polyphenols, phenolic acids, isoprenoids and oligosaccharides performing in the gastrointestinal tract may reduce reactive oxygen species, control pathways of inflammation, attach to carbohydrates and proteins on surfaces of bacteria, employ prebiotic effects, and change the transmission of signals between intestinal epithelial cells and the gut microbiota. | [ |
| Flu virus | High molecular weight substances (NDM) in cranberry inhibited Influenza virus A subtypes (H1N1 and H3N2) and the B type, which was shown by the cytopathic effect on Madine-Darby canine kidney (MDCK) cells and the lack of hemagglutination of red blood cells activity in infected cells. | [ |
| Microbial | Cranberry phenolic extracts impeded the growth of human pathogenic bacteria: | [ |